Abstract
Action myoclonus renal failure syndrome (AMRF) is a rare form of progressive myoclonic epilepsy (PME) associated with severe renal failure. AMRF is an autosomal recessive (AR) disease manifested by the development of neurologic and/or renal symptoms in the 2nd and 3rd decades. The disease occurs due to mutations in SCARB2, which encodes the lysosomal integral membrane type 2 (LIMP-2) protein [1].
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.